Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, People's Republic of China.
Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, People's Republic of China.
Eur J Med Res. 2024 Mar 12;29(1):161. doi: 10.1186/s40001-024-01741-7.
In cancer patients receiving immune checkpoint inhibitors (ICIs), there is emerging evidence suggesting a correlation between gut microbiota and immune-related adverse events (irAEs). However, the exact roles of gut microbiota and the causal associations are yet to be clarified.
To investigate this, we first conducted a univariable bi-directional two-sample Mendelian randomization (MR) analysis. Instrumental variables (IVs) for gut microbiota were retrieved from the MiBioGen consortium (18,340 participants). GWAS summary data for irAEs were gathered from an ICIs-treated cohort with 1,751 cancer patients. Various MR analysis methods, including inverse variance weighted (IVW), MR PRESSO, maximum likelihood (ML), weighted median, weighted mode, and cML-MA-BIC, were used. Furthermore, multivariable MR (MVMR) analysis was performed to account for possible influencing instrumental variables.
Our analysis identified fourteen gut bacterial taxa that were causally associated with irAEs. Notably, Lachnospiraceae was strongly associated with an increased risk of both high-grade and all-grade irAEs, even after accounting for the effect of BMI in the MVMR analysis. Akkermansia, Verrucomicrobiaceae, and Anaerostipes were found to exert protective roles in high-grade irAEs. However, Ruminiclostridium6, Coprococcus3, Collinsella, and Eubacterium (fissicatena group) were associated with a higher risk of developing high-grade irAEs. RuminococcaceaeUCG004, and DefluviitaleaceaeUCG011 were protective against all-grade irAEs, whereas Porphyromonadaceae, Roseburia, Eubacterium (brachy group), and Peptococcus were associated with an increased risk of all-grade irAEs.
Our analysis highlights a strong causal association between Lachnospiraceae and irAEs, along with some other gut microbial taxa. These findings provide potential modifiable targets for managing irAEs and warrant further investigation.
在接受免疫检查点抑制剂(ICI)治疗的癌症患者中,越来越多的证据表明肠道微生物群与免疫相关不良事件(irAEs)之间存在相关性。然而,肠道微生物群的确切作用和因果关系尚不清楚。
为了研究这一点,我们首先进行了单变量双向两样本孟德尔随机化(MR)分析。肠道微生物群的工具变量(IVs)从 MiBioGen 联盟(18340 名参与者)中检索。irAEs 的 GWAS 汇总数据来自 1751 名接受 ICI 治疗的癌症患者队列。使用了各种 MR 分析方法,包括逆方差加权(IVW)、MR PRESSO、最大似然(ML)、加权中位数、加权模式和 cML-MA-BIC。此外,还进行了多变量 MR(MVMR)分析,以考虑可能影响工具变量的因素。
我们的分析确定了 14 种与 irAEs 有因果关系的肠道细菌。值得注意的是,lachnospiraceae 与高等级和所有等级的 irAEs 的风险增加密切相关,即使在 MVMR 分析中考虑了 BMI 的影响也是如此。 Akkermansia、Verrucomicrobiaceae 和 Anaerostipes 被发现对高等级 irAEs 有保护作用。然而,Ruminiclostridium6、Coprococcus3、Collinsella 和 Eubacterium(fissicatena 组)与高等级 irAEs 的风险增加相关。RuminococcaceaeUCG004 和 DefluviitaleaceaeUCG011 对所有等级的 irAEs 有保护作用,而 Porphyromonadaceae、Roseburia、Eubacterium(brachy 组)和 Peptococcus 与所有等级的 irAEs 的风险增加相关。
我们的分析强调了 Lachnospiraceae 与 irAEs 之间的因果关系,以及其他一些肠道微生物群。这些发现为管理 irAEs 提供了潜在的可调节靶点,值得进一步研究。